A clinical trial of TH-104 for temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders entering an area contaminated with high-potency opioids
Latest Information Update: 30 Jul 2025
At a glance
- Drugs Nalmefene (Primary)
- Indications Opioid-related disorders
- Focus Registrational; Therapeutic Use
Most Recent Events
- 30 Jul 2025 New trial record